For: | Milionis C, Ilias I, Koukkou E. Progesterone in gender-affirming therapy of trans women. World J Biol Chem 2022; 13(3): 66-71 [PMID: 35721880 DOI: 10.4331/wjbc.v13.i3.66] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v13/i3/66.htm |
Number | Citing Articles |
1 |
Rebecca C. Sagar, Victoria Millson-Brown. Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective. Best Practice & Research Clinical Endocrinology & Metabolism 2024; 38(5): 101921 doi: 10.1016/j.beem.2024.101921
|
2 |
Melissa Emily Wright, Kevin Murphy. A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health. Frontiers in Human Neuroscience 2023; 17 doi: 10.3389/fnhum.2023.1303871
|
3 |
Alexandra Schuetz, Michael J. Corley, Carlo Sacdalan, Yuwadee Phuang-Ngern, Thitiyanun Nakpor, Tanyaporn Wansom, Philip K. Ehrenberg, Somchai Sriplienchan, Rasmi Thomas, Nisakorn Ratnaratorn, Suchada Sukhumvittaya, Nipattra Tragonlugsana, Bonnie M. Slike, Siriwat Akapirat, Suteeraporn Pinyakorn, Rungsun Rerknimitr, Alina P.S. Pang, Eugène Kroon, Nipat Teeratakulpisan, Shelly J. Krebs, Nittaya Phanuphak, Lishomwa C. Ndhlovu, Sandhya Vasan. Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisition. JCI Insight 2023; 8(16) doi: 10.1172/jci.insight.169272
|